← All companies

NKTP

Nok Therapeutics, Inc.

NKTP Pharmaceutical Preparations EDGAR ↗

—

—

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

—

Recent SEC filings

33 most recent

Other filings

1-U Item 9.1 Jul 15, 2026 1-U Item 7 Jun 3, 2026 D/A Item 06b May 1, 2026 D/A Item 06b May 1, 2026 1-K Apr 30, 2026 D/A Item 06b Apr 22, 2026 D/A Item 06b Apr 22, 2026 D/A Item 06b Apr 22, 2026 D Item 06b Mar 26, 2026 D Item 06b Oct 24, 2025 D Item 06b Oct 24, 2025 1-SA SEMIANNUAL REPORT PURSUANT TO REGULATION A Sep 30, 2025 1-K May 6, 2025 QUALIF Jan 3, 2025 CORRESP Dec 30, 2024 CORRESP Dec 23, 2024 1-A/A Dec 23, 2024 UPLOAD Dec 20, 2024 CORRESP Dec 17, 2024 1-A/A Dec 17, 2024 UPLOAD Dec 13, 2024 CORRESP Dec 9, 2024 1-A/A Dec 9, 2024 UPLOAD Dec 3, 2024 CORRESP Nov 26, 2024 1-A/A Nov 26, 2024 CORRESP Nov 25, 2024 1-A/A Nov 25, 2024 UPLOAD Nov 19, 2024 1-A/A Nov 7, 2024 CORRESP Nov 7, 2024 UPLOAD Oct 23, 2024 1-A Sep 26, 2024